Arcus Biosciences, Inc. (RCUS)
Arcus Biosciences Market Cap : 3.008B for May 21, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Gilead Sciences, Inc. | 161.98B |
| ACADIA Pharmaceuticals, Inc. | 3.651B |
| Alnylam Pharmaceuticals, Inc. | 40.13B |
| Amgen, Inc. | 182.24B |
| Catalyst Pharmaceuticals, Inc. | 3.829B |
Market Cap Related Metrics
| PS Ratio | 11.58 |
| Price to Book Value | 5.740 |
| Price | 23.92 |
| Earnings Yield | -13.31% |